Home
/ MABION
/ Competitors

MABION Competitors and Similar CompaniesClear all

MABION's competitors and similar companies include Eureka Therapeutics, Lion TCR, Oncologie and OncoTherapy Science.

	MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.	Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.	Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.	Oncologie Oncologie is a biopharmaceutical company.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Founding Date	Founding Date 2007	Founding Date 2006	Founding Date N/A	Founding Date 2018	Founding Date 2001
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare bioengineering biotech drug development oncology therapy	Tags Healthcare bioengineering drug development oncology therapy	Tags Healthcare bioengineering biotech clinical research drug development oncology therapy	Tags Healthcare bioengineering biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Konstantynów Łódzki, PL HQ	Locations Emeryville, US HQ	Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG	Locations Waltham, US HQ Shanghai, CN Boston, US	Locations Kawasaki, JP HQ
Employees	Employees 95	Employees 432% decrease	Employees N/A	Employees 8	Employees 54
Valuation ($)	Valuation ($) 21.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 56.9 m
Financial
Revenue (est.)	Revenue (est.) zł15.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥808.5m (FY, 2026)
Cost of goods	Cost of goods zł24.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥794.6m (FY, 2026)
Gross profit	Gross profit (zł7.2m) (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥14m (FY, 2026)
Net income	Net income (zł62.6m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income (¥910.6m) (FY, 2026)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 45m (about 6 years ago)	Latest funding round $ 20m (about 8 years ago)	Latest funding round $ 80m (almost 7 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 130.4m	Total funding raised $ 20m	Total funding raised $ 96.5m	Total funding raised N/A